Uhh… cause using a gene-editing technology to artificially reduce natural genetic diversity in humans for monetary gain without years and years of clinical trials might, just might, have some serious ethical hurdles in front of it?
> using a gene-editing technology to artificially reduce natural genetic diversity in humans for monetary gain
There could be a regulation that they must artificially increase (or at least balance) natural genetic diversity as well by putting some random mutations in the genome every time they clear out something like colorblindness or huntington's disease or cystic fibrosis. Maybe this will help speed it through FDA approval.
Other applications are vastly more valuable. 'Curing' colorblindness has to be one of the least useful applications of this new, expensive, and mostly untested tech.
